Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,679.20
-3.90 (-0.23%)
Jun 6, 2025, 3:29 PM IST

NSE:SUNPHARMA Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
109,29095,76484,73632,72729,038
Upgrade
Depreciation & Amortization
25,75424,90624,77121,09020,296
Upgrade
Other Amortization
-661.7533.4435.8503.9
Upgrade
Loss (Gain) From Sale of Assets
235.31,662227.11,65616.7
Upgrade
Asset Writedown & Restructuring Costs
--1.5-10-88.7-
Upgrade
Loss (Gain) From Sale of Investments
-2,514-921.96.23,126-2,596
Upgrade
Provision & Write-off of Bad Debts
1,808905.92,071175.743.1
Upgrade
Other Operating Activities
9,383-12,248-6,12215,133-11,239
Upgrade
Change in Accounts Receivable
-16,0213,529-9,532-13,423937.3
Upgrade
Change in Inventory
-1,8405,988-12,0223,070-10,803
Upgrade
Change in Accounts Payable
5,2802,49711,8243,6993,815
Upgrade
Change in Other Net Operating Assets
9,345-1,393-46,88822,24431,692
Upgrade
Operating Cash Flow
140,721121,35049,59389,84561,704
Upgrade
Operating Cash Flow Growth
15.96%144.69%-44.80%45.61%-5.86%
Upgrade
Capital Expenditures
-21,286-22,018-20,856-14,950-11,701
Upgrade
Sale of Property, Plant & Equipment
610.1308.4210.1606.1971
Upgrade
Cash Acquisitions
-2,728-1,433-46,858-7,396-616
Upgrade
Divestitures
---238.4-
Upgrade
Investment in Securities
-38,6429,325-16,436-37,91113,733
Upgrade
Other Investing Activities
8,6987,1234,5032,1012,094
Upgrade
Investing Cash Flow
-53,062-6,902-79,437-57,2475,362
Upgrade
Short-Term Debt Issued
-1,430-1,064-
Upgrade
Long-Term Debt Issued
33,61745,72781,59816,56866,029
Upgrade
Total Debt Issued
33,61747,15781,59817,63266,029
Upgrade
Short-Term Debt Repaid
-482--1,305--1,726
Upgrade
Long-Term Debt Repaid
-44,784-82,287-30,010-45,286-109,199
Upgrade
Total Debt Repaid
-45,266-82,287-31,315-45,286-110,925
Upgrade
Net Debt Issued (Repaid)
-11,649-35,13050,283-27,654-44,896
Upgrade
Repurchase of Common Stock
-----559.5
Upgrade
Common Dividends Paid
-36,140-28,982-25,189-21,589-15,595
Upgrade
Other Financing Activities
-31,270-2,990-1,333-2,6921,246
Upgrade
Financing Cash Flow
-79,058-67,10223,761-51,935-59,805
Upgrade
Foreign Exchange Rate Adjustments
1,230-739.91,5711,274-1,297
Upgrade
Miscellaneous Cash Flow Adjustments
-0.312.95,667414.5-
Upgrade
Net Cash Flow
9,83146,6191,155-17,6485,964
Upgrade
Free Cash Flow
119,43599,33228,73874,89550,002
Upgrade
Free Cash Flow Growth
20.24%245.65%-61.63%49.78%-0.25%
Upgrade
Free Cash Flow Margin
22.72%20.48%6.55%19.38%14.93%
Upgrade
Free Cash Flow Per Share
49.8341.4011.9831.2120.84
Upgrade
Cash Interest Paid
2,2382,1901,325732.11,443
Upgrade
Cash Income Tax Paid
4,76815,69415,098-9,69210,029
Upgrade
Levered Free Cash Flow
70,45575,8287,91175,69384,289
Upgrade
Unlevered Free Cash Flow
71,90177,3188,98676,48985,173
Upgrade
Change in Net Working Capital
10,759-8,01753,623-18,938-35,902
Upgrade
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.